AAAAAA

   
Results: 1-12 |
Results: 12
In vitro testing of pharmaceutical aerosols and predicting lung depositionfrom in vitro measurements
Authors: Clark, A Borgstrom, L
Citation: A. Clark et L. Borgstrom, In vitro testing of pharmaceutical aerosols and predicting lung depositionfrom in vitro measurements, LUNG BIOL H, 162, 2002, pp. 105-142
Dry-powder inhalers
Authors: Borgstrom, L Bisgaard, H O'Callaghan, C Pedersen, S
Citation: L. Borgstrom et al., Dry-powder inhalers, LUNG BIOL H, 162, 2002, pp. 421-448
Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the turbuhaler in asthmatic individuals
Authors: Derom, E Borgstrom, L Van Schoor, J Lofroos, AB Pauwels, R
Citation: E. Derom et al., Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the turbuhaler in asthmatic individuals, AM J R CRIT, 164(8), 2001, pp. 1398-1402
Cumulative and single-dose design to assess the bronchodilator effects of beta(2)-agonists in individuals with asthma
Authors: Fishwick, D Bradshaw, L MacDonald, C Beasley, R Gash, D Bengtsson, T Bondesson, E Borgstrom, L
Citation: D. Fishwick et al., Cumulative and single-dose design to assess the bronchodilator effects of beta(2)-agonists in individuals with asthma, AM J R CRIT, 163(2), 2001, pp. 474-477
The importance of the device in asthma therapy
Authors: Borgstrom, L
Citation: L. Borgstrom, The importance of the device in asthma therapy, RESP MED, 95, 2001, pp. S26-S29
Equivalent therapeutic ratio, of salbutamol given by Turbuhaler((R)) and Diskus((R)) (Respir Med 2000, 94 : 574-577)
Authors: Borgstrom, L
Citation: L. Borgstrom, Equivalent therapeutic ratio, of salbutamol given by Turbuhaler((R)) and Diskus((R)) (Respir Med 2000, 94 : 574-577), RESP MED, 95(6), 2001, pp. 534-535
On the use of dry powder inhalers in situations perceived as constrained
Authors: Borgstrom, L
Citation: L. Borgstrom, On the use of dry powder inhalers in situations perceived as constrained, J AEROSOL M, 14(3), 2001, pp. 281-287
Pulmonary clearance rate of two chemically different forms of inhaled pertechnetate
Authors: Walker, PS Conway, JH Fleming, JS Bondesson, E Borgstrom, L
Citation: Ps. Walker et al., Pulmonary clearance rate of two chemically different forms of inhaled pertechnetate, J AEROSOL M, 14(2), 2001, pp. 209-215
Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler (R)
Authors: Borgstrom, L Bengtsson, T Derom, E Pauwels, R
Citation: L. Borgstrom et al., Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler (R), INT J PHARM, 193(2), 2000, pp. 227-230
In vitro, ex vivo, in vivo veritas
Authors: Borgstrom, L
Citation: L. Borgstrom, In vitro, ex vivo, in vivo veritas, ALLERGY, 54, 1999, pp. 88-92
The pharmacokinetics of inhaled hydroflouroalkane formulations
Authors: Borgstrom, L
Citation: L. Borgstrom, The pharmacokinetics of inhaled hydroflouroalkane formulations, J ALLERG CL, 104(6), 1999, pp. S246-S249
Lung deposition of budesonide from Turbuhaler in asthmatic children
Authors: Wildhaber, JH Devadason, SG Wilson, JM Roller, C Lagana, T Borgstrom, L LeSouef, PN
Citation: Jh. Wildhaber et al., Lung deposition of budesonide from Turbuhaler in asthmatic children, EUR J PED, 157(12), 1998, pp. 1017-1022
Risultati: 1-12 |